{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:20:06Z","timestamp":1787959206394,"version":"build-2784847793"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study aimed to investigate radiomics based on primary nonsmall-cell lung cancer (NSCLC) and distant metastases to predict epidermal growth factor receptor (EGFR) mutation status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 290 patients (mean age, 58.21 \u00b1 9.28) diagnosed with brain (BM, n = 150) or spinal bone metastasis (SM, n = 140) from primary NSCLC were enrolled as a primary cohort. An external validation cohort, consisting of 69 patients (mean age, 59.87 \u00b1 7.23; BM, n = 36; SM, n = 33), was enrolled from another center. Thoracic computed tomography\u2013based features were extracted from the primary tumor and peritumoral area and selected using the least absolute shrinkage and selection operator regression to build a radiomic signature (RS-primary). Contrast-enhanced magnetic resonance imaging\u2013based features were calculated and selected from the BM and SM to build RS-BM and RS-SM, respectively. The RS-BM-Com and RS-SM-Com were developed by integrating the most important features from the primary tumor, BM, and SM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Six computed tomography\u2013based features showed high association with EGFR mutation status: 3 from intratumoral and 3 from peritumoral areas. By combination of features from primary tumor and metastases, the developed RS-BM-Com and RS-SM-Com performed well with areas under curve in the training (RS-BM-Com vs RS-BM, 0.936 vs 0.885, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.177; RS-SM-Com vs RS-SM, 0.929 vs 0.843, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003), internal validation (RS-BM-Com vs RS-BM, 0.920 vs 0.858, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.492; RS-SM-Com vs RS-SM, 0.896 vs 0.859, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.379), and external validation (RS-BM-Com vs RS-BM, 0.882 vs 0.805, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.263; RS-SM-Com vs RS-SM, 0.865 vs 0.816, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.312) cohorts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study indicates that the accuracy of detecting EGFR mutations significantly enhanced in the presence of metastases in primary NSCLC. The established radiomic signatures from this approach may be useful as new predictors for patients with distant metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000001591","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T19:02:38Z","timestamp":1710788558000},"page":"780-788","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis"],"prefix":"10.1097","volume":"48","author":[{"given":"Yue","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Geng","sequence":"additional","affiliation":[{"name":"School of Intelligent Medicine, China Medical University, Liaoning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department of Thoracic Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Liaoning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shengjing Hospital of China Medical University, Shenyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Iconography, Liaoning Cancer Hospital & Institute, Liaoning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langyuan","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Intelligent Medicine, China Medical University, Liaoning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Liaoning Cancer Hospital and Institute, Liaoning"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Scientific Research and Academic, Liaoning Cancer Hospital and Institute, Liaoning, People's Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"bib1-20250802","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250802","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.lungcan.2007.03.012","article-title":"National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care","volume":"57","year":"2007","journal-title":"Lung Cancer"},{"key":"bib3-20250802","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","year":"2014","journal-title":"Lung Cancer"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11864-003-0033-8","article-title":"Solitary sites of metastatic disease in non-small cell lung cancer","volume":"4","year":"2003","journal-title":"Curr Treat Options Oncol"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review","volume":"322","year":"2019","journal-title":"JAMA"},{"key":"bib6-20250802","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/mco.2014.410","article-title":"Specific organ metastases and survival in metastatic non-small-cell lung cancer","volume":"3","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"bib7-20250802","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-016-2169-5","article-title":"Distribution and prognosis of uncommon metastases from non-small cell lung cancer","volume":"16","year":"2016","journal-title":"BMC Cancer"},{"key":"bib8-20250802","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1986.4.5.702","article-title":"Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study","volume":"4","year":"1986","journal-title":"J Clin Oncol"},{"key":"bib9-20250802","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cllc.2013.05.002","article-title":"Determinants of survival in advanced non\u2013small-cell lung cancer in the era of targeted therapies","volume":"14","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.3747\/co.20.1481","article-title":"Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases","volume":"20","year":"2013","journal-title":"Curr Oncol"},{"key":"bib11-20250802","first-page":"535","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases [published correction appears in Nat Rev Cancer. 2015 Apr;15(4):247]","volume":"14","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"bib12-20250802","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2007.03.013","article-title":"Skeletal metastases in non-small cell lung cancer: a retrospective study","volume":"57","year":"2007","journal-title":"Lung Cancer"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00432-018-2702-9","article-title":"The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study","volume":"144","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jtho.2020.12.002","article-title":"Recent advances on the role of EGFR tyrosine kinase inhibitors in the management of NSCLC with uncommon, non exon 20 insertions, EGFR mutations","volume":"16","year":"2021","journal-title":"J Thorac Oncol"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.1158\/0008-5472.CAN-06-0453","article-title":"Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib","volume":"66","year":"2006","journal-title":"Cancer Res"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.lungcan.2019.07.024","article-title":"Additional local consolidative therapy has survival benefit over EGFR tyrosine kinase inhibitors alone in bone oligometastatic lung adenocarcinoma patients","volume":"135","year":"2019","journal-title":"Lung Cancer"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"e11346","DOI":"10.1097\/MD.0000000000011346","article-title":"Association between advanced NSCLC T790 M EGFR-TKI secondary resistance and prognosis: a observational study","volume":"97","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"18590","DOI":"10.18632\/oncotarget.14613","article-title":"Liquid biopsy genotyping in lung cancer: ready for clinical utility?","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1183\/09031936.00010111","article-title":"Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma","volume":"39","year":"2012","journal-title":"Eur Respir J"},{"key":"bib20-20250802","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1158\/1078-0432.CCR-17-2507","article-title":"A new approach to predict progression-free survival in stage IV EGFR-mutant NSCLC patients with EGFR-TKI therapy","volume":"24","year":"2018","journal-title":"Clin Cancer Res"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2020.05.022","article-title":"Radiomics for precision medicine: current challenges, future prospects, and the proposal of a new framework","volume":"188","year":"2021","journal-title":"Methods"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-019-04372-x","article-title":"Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"108991","DOI":"10.1016\/j.ejrad.2020.108991","article-title":"A review of original articles published in the emerging field of radiomics","volume":"127","year":"2020","journal-title":"Eur J Radiol"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2019.03.025","article-title":"Radiomics signature: a potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology","volume":"132","year":"2019","journal-title":"Lung Cancer"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40644-018-0184-2","article-title":"CT texture analysis of lung adenocarcinoma: can radiomic features be surrogate biomarkers for EGFR mutation statuses","volume":"18","year":"2018","journal-title":"Cancer Imaging"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"e13963","DOI":"10.1097\/MD.0000000000013963","article-title":"Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?","volume":"98","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"bib27-20250802","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cllc.2016.02.001","article-title":"Radiomic features are associated with EGFR mutation status in lung adenocarcinomas","volume":"17","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"bib28-20250802","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tranon.2017.10.012","article-title":"Quantitative biomarkers for prediction of epidermal growth factor receptor mutation in non-small cell lung cancer","volume":"11","year":"2018","journal-title":"Transl Oncol"},{"key":"bib29-20250802","doi-asserted-by":"crossref","first-page":"41674","DOI":"10.1038\/srep41674","article-title":"Predictive radiogenomics modeling of EGFR mutation status in lung cancer","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib30-20250802","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jmri.25572","article-title":"Lung adenocarcinoma: assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image","volume":"46","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"bib31-20250802","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41598-020-60202-3","article-title":"Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"bib32-20250802","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1038\/s41598-020-65470-7","article-title":"Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer","volume":"10","year":"2020","journal-title":"Sci Rep"},{"key":"bib33-20250802","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1007\/s00330-020-07614-x","article-title":"Radiomics signature of brain metastasis: prediction of EGFR mutation status","volume":"31","year":"2021","journal-title":"Eur Radiol"},{"key":"bib34-20250802","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1002\/mp.15137","article-title":"MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients","volume":"48","year":"2021","journal-title":"Med Phys"},{"key":"bib35-20250802","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jmri.27579","article-title":"Multiparametric MRI-based radiomics approaches for preoperative prediction of EGFR mutation status in spinal bone metastases in patients with lung adenocarcinoma","volume":"54","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"bib36-20250802","article-title":"Subregional radiomics analysis for the detection of the EGFR mutation on thoracic spinal metastases from lung cancer","volume":"66","year":"2021","journal-title":"Phys Med Biol"},{"key":"bib37-20250802","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","year":"2017","journal-title":"Cancer Res"},{"key":"bib38-20250802","first-page":"155","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research [published correction appears in J Chiropr Med. 2017 Dec;16(4):346]","volume":"15","year":"2016","journal-title":"J Chiropr Med"},{"key":"bib39-20250802","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0006-341X.2001.00120.x","article-title":"Akaike's information criterion in generalized estimating equations","volume":"57","year":"2001","journal-title":"Biometrics"},{"key":"bib40-20250802","article-title":"Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods","volume":"10","year":"2000","journal-title":"Adv Large Margin Classif"},{"key":"bib41-20250802","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","year":"2001","journal-title":"Mach learn"},{"key":"bib42-20250802","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/07853899509002462","article-title":"Artificial neural networks for decision support in clinical medicine","volume":"27","year":"1995","journal-title":"Ann Med"},{"issue":"1\u20132","key":"bib43-20250802","first-page":"41","article-title":"Dual coordinate descent methods for logistic regression and maximum entropy models","volume":"85","year":"2011","journal-title":"Mach Learn"},{"key":"bib44-20250802","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","year":"2008","journal-title":"Biom J"},{"key":"bib45-20250802","doi-asserted-by":"crossref","first-page":"102820","DOI":"10.1016\/j.critrevonc.2019.102820","article-title":"Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: review of the literature and future perspectives","volume":"146","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"bib46-20250802","doi-asserted-by":"crossref","first-page":"1800986","DOI":"10.1183\/13993003.00986-2018","article-title":"Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning","volume":"53","year":"2019","journal-title":"Eur Respir J"},{"key":"bib47-20250802","doi-asserted-by":"crossref","first-page":"e0206108","DOI":"10.1371\/journal.pone.0206108","article-title":"Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC","volume":"13","year":"2018","journal-title":"PLoS One"},{"key":"bib48-20250802","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JTO.0000000000000486","article-title":"Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas","volume":"10","year":"2015","journal-title":"J Thorac Oncol"},{"key":"bib49-20250802","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","year":"2021","journal-title":"Cancers (Basel)"},{"key":"bib50-20250802","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","year":"2016","journal-title":"Radiology"},{"key":"bib51-20250802","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/23808993.2016.1164013","article-title":"Radiomics: a new application from established techniques","volume":"1","year":"2016","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"bib52-20250802","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","year":"2011","journal-title":"Lancet Oncol"},{"key":"bib53-20250802","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s11227-021-03901-6","article-title":"Deep learning techniques for tumor segmentation: a review","volume":"78","year":"2022","journal-title":"J Supercomput"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T23:08:54Z","timestamp":1754176134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001591","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}